MRTX

Mirati Therapeutics, Inc. Common Stock
MRTX

Overview Fund Activity
Delisted

MRTX was delisted on the 22nd of January, 2024.

Back to rankings

33 hedge funds and large institutions have $172M invested in Mirati Therapeutics, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+7
Holders Change %
+26.92%
% of All Funds
0.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
11
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$13.4M
2
Franklin Resources
Franklin Resources
California
+$4.58M
3
DCM
Driehaus Capital Management
Illinois
+$4.54M
4
AG
Artal Group
Luxembourg
+$1.43M
5
Morgan Stanley
Morgan Stanley
New York
+$873K

Top Sellers

1
TCM
Tang Capital Management
California
-$9.59M
2
First Eagle Investment Management
First Eagle Investment Management
New York
-$4.53M
3
BI
BVF Inc
California
-$1.13M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$832K
5
BC
Broadfin Capital
New York
-$563K
Name Holding Trade Value Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
$68K +$55.1K +2,882 +426%
TRCT
27
Tower Research Capital (TRC)
New York
$52K +$15.3K +787 +42%
BIT
28
BlackRock Institutional Trust
California
$42K +$42K +2,224 New
Barclays
29
Barclays
United Kingdom
$17K +$17K +887 New
TC
30
TradeLink Capital
Illinois
$10K +$10K +500 New
BRWM
31
B. Riley Wealth Management
Tennessee
$2K +$2K +82 New
Citigroup
32
Citigroup
New York
$1K +$1K +29 New
Alyeska Investment Group
33
Alyeska Investment Group
Illinois
– -$832K -50,000 Closed
TC
34
TFS Capital
Pennsylvania
– -$291K -17,510 Closed
SM
35
Sabby Management
Florida
– -$203K -12,213 Closed
AP
36
Advisors Preferred
Maryland
– -$6K -385 Closed
1
2